Skip to content
Medical Health Aged Care

RACGP welcomes Winter Strategy to protect Western Australians

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has welcomed the WA Department of Health’s 2026 Winter Strategy, acknowledging it as an important investment in reducing preventable illness and easing pressure on the state’s health system during the peak winter period.

RACGP WA Chair Dr Ramya Raman said the expanded vaccination programs will help protect communities, especially children and working age adults who are often under vaccinated.

“Winter places enormous strain on our health system, and these proactive measures will make a meaningful difference. Free access to influenza vaccination for more Western Australians will reduce severe illness, keep people well, and help prevent avoidable hospitalisations,” Dr Raman said.

The RACGP WA strongly supports the Department’s decision to again fund free influenza vaccines for people aged 12–64 who are not eligible under the National Immunisation Program, running from 1 May to 30 June 2026, and to support GPs and other health providers with grants to deliver more vaccinations.

“This program has proven benefits. Removing cost barriers helps ensure more people are protected, particularly working families and younger adults who may otherwise delay vaccination. It’s a smart, equitable investment in public health,” Dr Raman said.

The College also welcomed the Department’s move to procure all vaccine stock required for the program.

“Central procurement avoids duplication, reduces waste, and ensures a more efficient, coordinated rollout for practices across the state.”

The RACGP also endorsed the 2026 WA Influenza Nasal Spray Vaccination Program, offering free FluMist intranasal vaccines to children aged 2–11 from mid April to 31 July 2026.

“Making an intranasal option available is a valuable addition, particularly for young children who are anxious about needles. It removes a barrier to vaccination, helps improve uptake, and supports families during the busy winter period,” Dr Raman said.

The College praised the Department’s plan for equitable pre-allocation of FluMist doses, noting its short shelf life.

“We appreciate the Department’s careful planning to ensure doses reach providers statewide without unnecessary wastage. This is exactly the kind of thoughtful, collaborative approach we want to see.”

The RACGP emphasised that general practice remains the backbone of vaccination delivery.

“GPs and practice nurses know their patients, understand their medical history, and are best placed to provide safe, holistic vaccine advice. These programs will only reach their full potential with strong support for general practice and recognition of the essential role we play,” Dr Raman said.

The College reaffirmed its commitment to working closely with the WA Government, the Department of Health, and immunisation providers to ensure a smooth rollout.

“This Winter Strategy is a positive step that puts prevention at the centre of public health planning. We look forward to partnering with government to ensure every eligible Western Australian can access timely, safe and effective vaccination this winter.”

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Senior Media Advisor

Stuart Winthrope
Media Advisor

Kevin Diggerson
Public Affairs Manager

Contact: 03 8699 0992[email protected]

Follow us on X and Facebook.

Media

More from this category

  • Medical Health Aged Care
  • 07/06/2026
  • 05:00
Dementia Australia

Join us today for the Gold Coast Memory Walk & Jog

What: Dementia Australia’s Gold Coast Memory Walk & Jog   When: Sunday 7 June from 7:30am   Who: More than 880 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Special guest MC Takaya Honda. Where: Pratten Park   Dementia Australia spokespeople and local residents are available for interview. Photos and video of previous Memory Walk & Jog events for publication are available for use. For more information visit: www.memorywalk.com.au Dementia Australia is the source of trusted information, education and services for the estimated more than 446,500 Australians living with dementia, and…

  • Contains:
  • Medical Health Aged Care
  • 06/06/2026
  • 05:00
Dementia Australia

Join us today for the Redcliffe Memory Walk & Jog

What: Dementia Australia’s Redcliffe Memory Walk & Jog   When: Saturday 6 June from 7:30am   Who: More than 880 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Special guests MC’s Pat Welsh and Wally Lewis. Where: Scarborough Beach Park   Dementia Australia spokespeople and local residents are available for interview. Photos and video of previous Memory Walk & Jog events for publication are available for use. For more information visit: www.memorywalk.com.au Dementia Australia is the source of trusted information, education and services for the estimated more than 446,500 Australians living…

  • Contains:
  • Medical Health Aged Care
  • 06/06/2026
  • 02:02
EnGeneIC

EnGeneIC Honored with 2026 Breakthrough in Glioblastoma Biotech Award at Northwell Foundation Lenox Hill Neurosurgery Brain Cancer Gala in New York

SYDNEY and NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- EnGeneIC Limited today announced it has been recognized with the Breakthrough in glioblastoma Biotech Award 2026 at the Northwell Foundation, Lenox Hill Neurosurgery Brain Tumor Center Gala event in New York City. The award was presented to Joint-CEO’s and co-inventors Dr. Himanshu Brahmbhatt and Dr. Jennifer MacDiarmid on June 4, 2026.The award recognizes EnGeneIC’s advancement of novel cyto-immunotherapy using its proprietary EnGeneIC Dream Vector (EDV™) nanocell platform. The technology is designed to bypass the blood brain barrier, selectively target tumors, deliver potent therapeutic payloads inside cancer cells, and activate both…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.